MedTrace Logo

Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures

NCT01746641 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2012-12-11

No results posted yet for this study

Summary

The purpose of this study was to compare remifentanil and propofol for sedation of patients during endoscopic gastrointestinal procedures.

Conditions

Interventions

DRUG

Remifentanil

DRUG

Propofol

Sponsors & Collaborators

  • Hospital de San Jose

    collaborator OTHER

  • Fundación Universitaria de Ciencias de la Salud

    lead OTHER

Principal Investigators

  • Luis A Muñoz, MD · Fundacion Universitaria de Ciencias de la Salud

  • Luis E Reyes, MD · Fundacion Universitaria de Ciencias de la Salud

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01746641 on ClinicalTrials.gov